Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression

Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression

Recent studies have underscored the cardioprotective properties of liraglutide. This research explores its impact on cardiac hypertrophy and heart failure following transverse aortic constriction (TAC). We found that liraglutide administration markedly ameliorated cardiac hypertrophy, fibrosis, and...

Full description

Bibliographic Details
Main Authors: Ruisha Li, Keyin Zhang, Zhenjun Xu, Yanrong Yu, Dongjin Wang, Kai Li, Wenxue Liu, Jun Pan
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Heliyon
Subjects:
Liraglutide
Cardiac hypertrophy
Heart failure
ANP
ER stress
Apoptosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024082604

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024082604

Similar Items